Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trial
Titel:
Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trial
Auteur:
Kreijtz, Joost H C M Goeijenbier, Marco Moesker, Fleur M van den Dries, Lennert Goeijenbier, Simone De Gruyter, Heidi L M Lehmann, Michael H Mutsert, Gerrie de van de Vijver, David A M C Volz, Asisa Fouchier, Ron A M van Gorp, Eric C M Rimmelzwaan, Guus F Sutter, Gerd Osterhaus, Albert D M E